Orion Oyj
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS
9 December 2025 at 17.30 EET
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly and indirectly by BlackRock, Inc. and its funds, and the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 8 December 2025 below five (5) per cent of Orion Corporation’s total shares.
Total positions of BlackRock, Inc. and its funds subject to notification:
| % of shares and voting rights (total of point A) | % of shares and voting rights through financial instruments (total of point B) | Total of both in % (points A + B) | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed or reached | Below 5% shares Below 5% voting rights | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right | 141,134,278 shares 744,770,339 voting rights |
| Position of previous notification (if applicable) | 5.01% shares Below 5% voting rights | 0.01% shares Below 5% voting rights | 5.03% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed:
Point A: Shares and voting rights:
| Class/type of shares ISIN code | Number of shares and voting rights | % of shares and voting rights | ||
| Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |
| FI0009014377 | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right | ||
| POINT A SUBTOTAL | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right | ||
Point B: Financial instruments according to SMA 9:6a:
| Type of financial instrument | Expiration date | Exercise / Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
| American Depositary Receipt (US68628Y1047) | N/A | N/A | Physical | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right |
| CFD | N/A | N/A | Cash | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right |
| POINT B SUBTOTAL | Below 5% shares Below 5% voting right | Below 5% shares Below 5% voting right |
Orion Corporation
| Liisa Hurme President and CEO | Mikko Kemppainen General Counsel |
Contact person:
Tuukka Hirvonen, Head of Investor Relations, Orion Corporation
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orionpharma.com
Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq Helsinki.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.11.12.2025 06:20:46 CET | Press release
Robex Announces Amendment to Arrangement Agreement With Predictive Discovery; Special Meeting Postponed to December 30, 2025
Bodor Laser Inc.11.12.2025 05:50:40 CET | Press release
Bodor Laser Provides All-in-One Profile Cutting Solution for Structural Steel Fabrication
Politecnico Milano10.12.2025 19:35:25 CET | Press release
Three new Bachelors of the Politecnico di Milano, delivered entirely in English, in three cities
CARRICK THERAPEUTICS LIMITED10.12.2025 19:30:00 CET | Press release
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Atlantica Sustainable Infrastructure LTD10.12.2025 19:18:17 CET | Press release
Atlantica Closes the Acquisition of Statkraft's Renewable Energy Platform in Canada
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom